The global respiratory syncytial virus attachment glycoprotein market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Respiratory syncytial virus or RSV is a common respiratory virus. It usually causes mild, cold-like symptoms and most people recover in a week or two, however, it is very serious especially for infants and older adults. The major factor accelerating the growth of the market is the increasing prevalence of respiratory syncytial virus (RSV) attachment glycoprotein across the globe. According to the National Institute of Allergy and Infectious Disease (NIH), almost all children become infected with RSV by age 2. Additionally, an estimated 75,000 to 125,000 of them are hospitalized each year. Furthermore, it affects an estimated 64 million people with a mortality rate of 160,000 each year. Hence, the rising incidence of the disease is driving the growth of the global respiratory syncytial virus attachment glycoproteins market during the forecast period.
To Request a Sample of our Report on Respiratory Syncytial Virus Attachment Glycoprotein Market: https://www.omrglobal.com/request-sample/respiratory-syncytial-virus-attachment-glycoprotein-market
Some major players operating in the market include Bavarian Nordic A/S, Sanofi S.A., and F. Hoffmann-La Roche Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2021, Sanofi announced Nirsevimab being developed in partnership with AstraZeneca. It is the first investigational extended half-life monoclonal antibody (mAb) that aims to protect all infants who enter the first RSV season when they are at the highest risk for severe RSV disease.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Bavarian Nordic A/S, Sanofi S.A., and F. Hoffmann-La Roche Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Respiratory Syncytial Virus Attachment Glycoprotein Market is Available @ https://www.omrglobal.com/industry-reports/respiratory-syncytial-virus-attachment-glycoprotein-market
Global Respiratory Syncytial Virus Attachment Glycoprotein Market Report by Segment
By Type
- VIS-RSV
- TRL-3D3
- AX-14
- MVA-RSV
- Others
By Application
- Clinics
- Hospitals
- Others
Global Respiratory Syncytial Virus Attachment Glycoprotein Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
